Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
McKinsey
Cerilliant
US Department of Justice
Moodys
Teva
Farmers Insurance
Argus Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

RYBIX ODT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Rybix Odt patents expire, and when can generic versions of Rybix Odt launch?

Rybix Odt is a drug marketed by Shionogi Inc and is included in one NDA.

The generic ingredient in RYBIX ODT is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
Drug patent expirations by year for RYBIX ODT
Medical Subject Heading (MeSH) Categories for RYBIX ODT
Synonyms for RYBIX ODT
( inverted exclamation markA)-cis-2-(Dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(-)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXANOL
(+-)-cis-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(+-)-cis-2-((Dimethylamino)methyl)-1-(m-methoxyphenyl)cyclohexanol hydrochloride
(+)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(+)-Tramadol Hydrochloride
(+)-Tramadol-d6 Hydrochloride
(+)-Tramadol,hydrochloride
(+)-trans-Tramadol Hydrochloride
(1R-cis)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1R,2R)-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(1R,2R)-2-(Dimethylaminomethyl)-1-(3-methoxyphenyl)-cyclohexanol hydrochloride
(1R,2R)-2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol;hydrochloride
(1R,2R)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1R,2R)-rel-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol
(1RS,2RS)-2-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol
(R,R)-tramadol hydrochloride
[(1R,2R)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]-N,N-dimethylmethanaminium chloride
1-(m-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexane-1-ol
1109217-84-6
148229-78-1
194602-08-9
2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-[ methyl]-1- cyclohexan-1-ol
2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXAN-1-OL
2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
2-Dimethylaminomethyl-1-(m-methoxyphenyl)cyclohexanol
204T882
22203-92-5
22204-88-2
2914-77-4
36282-47-0
3B1-000741
53611-16-8
AB1009456
AC-796
AC1L1KJ8
AC1L1Y7D
AC1Q7AST
ACM2914774
Adolanta
AK153206
AK402423
AKOS015907739
AKOS022507395
Amadol
AN-15516
AN-32783
API0000067
API0004461
AX8154449
BC202864
Bellatram
C16H25NO2.HCl
CCG-101135
Cemadol
CG 315
CG-315E
CHEBI:75722
CHEBI:75733
CHEMBL1200336
CHEMBL1237044
cis-(+-)-E 383 hydrochloride
cis-(+/-)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
cis-(1)-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
cis-Tramadol hydrochloride
cis-Tramadol hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Contramal
ConZip
COR0000099
CPD000449308
CS-2770
CTK4G2807
CTK8G3518
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, (1R,2R)-rel-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-( -)-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-(+-)-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(m-methoxyphenyl)-, hydrochloride, cis-(+-)-
Cyclohexanol, 2-(dimethylaminomethyl)-1-(m-methoxyphenyl)-
Cyclohexanol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
Cyclohexanol,2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
D01355
D05GKD
Dolana
DTXSID7023691
E 382
EINECS 220-831-4
EINECS 252-950-2
EINECS 258-662-3
FT-0638197
FT-0675345
FT-0675347
GTPL8286
HSDB 7047
HY-B0582A
I14-2711
Ira-Tramadol
Jsp004511
K-8120
KS-1124
L000985
LS-174590
LS-191406
LS-57112
LS-57113
LS-57114
LS-57120
Mabron
Maxitram
MCULE-1882520267
MCULE-3504250719
Melanate
MFCD00798507
MLS000758218
MLS001424208
NC00385
NIH 10969
Omnidol
OR009034
OR148688
OR148689
Poltram
PPKXEPBICJTCRU-XMZRARIVSA-N
Q-201847
Radol
RT-015840
Rybix
Ryzolt
SAM001246847
SAM001247044
SBB067292
SC-77562
SCHEMBL41748
SCHEMBL57496
SMR000449308
Synapryn
Tadol
Tilodol
TL8001847
Trabar
Tradol-Puren
Tradonal
Tramadex
Tramadol HCl
Tramadol HCl; (+/-)cis-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanolhydrochloride
tramadol hydrochloride
Tramadol hydrochloride (JAN/USAN)
Tramadol hydrochloride [USAN:JAN]
Tramadol hydrochloride [USAN:USP:JAN]
Tramadol Hydrochloride 1.0 mg/ml in Methanol (as free base)
tramadol hydrochloride tablets
Tramadol hydrochloride, >=98% (HPLC), solid
Tramadol hydrochloride, >=99.0% (HPLC)
Tramadol hydrochloride, British Pharmacopoeia (BP) Reference Standard
Tramadol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tramadol hydrochloride, United States Pharmacopeia (USP) Reference Standard
TRAMADOL/HCL
tramadole hydrochloride
TRAMADOLHydrochloride
Tramagetic
Tramal
Tramal Retard
Tramazac
Tramed
Tramol
Tridol
Tridural
TVYLLZQTGLZFBW-UHFFFAOYSA-N
U 26,225A
U-26,225A
U-26225A
Ultram
Ultram (TN)
Ultram ER
UNII-9N7R477WCK component PPKXEPBICJTCRU-XMZRARIVSA-N
Viotra
W0081
Zumatran
Zydol
Zydol hydrochloride
Zydol XL 150

US Patents and Regulatory Information for RYBIX ODT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shionogi Inc RYBIX ODT tramadol hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021693-001 May 5, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for RYBIX ODT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shionogi Inc RYBIX ODT tramadol hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021693-001 May 5, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Shionogi Inc RYBIX ODT tramadol hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021693-001 May 5, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
US Army
Accenture
Farmers Insurance
UBS
Cerilliant
Baxter
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.